Compare DINO & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DINO | MEDP |
|---|---|---|
| Founded | 1947 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 15.4B |
| IPO Year | 2022 | 2016 |
| Metric | DINO | MEDP |
|---|---|---|
| Price | $91.70 | $530.93 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 12 |
| Target Price | $61.50 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 2.3M | 312.5K |
| Earning Date | 05-01-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.03% | N/A |
| EPS Growth | ★ 238.46 | 20.98 |
| EPS | 3.56 | ★ 4.28 |
| Revenue | N/A | N/A |
| Revenue This Year | $8.01 | $13.19 |
| Revenue Next Year | N/A | $7.75 |
| P/E Ratio | ★ $25.40 | $123.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $42.16 | $373.00 |
| 52 Week High | $91.45 | $628.92 |
| Indicator | DINO | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 82.76 | 56.94 |
| Support Level | $47.04 | $525.92 |
| Resistance Level | N/A | $530.97 |
| Average True Range (ATR) | 2.55 | 17.19 |
| MACD | 1.63 | -3.92 |
| Stochastic Oscillator | 93.90 | 27.49 |
HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 350 distributors and 1,700 wholesale branded sites across 30 states. It also owns and operates 4,500 miles of petroleum product pipelines and terminals principally in the southwestern United States.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.